Product Images Cyclobenzaprine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Cyclobenzaprine Hydrochloride NDC 52817-332 by Trupharma Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

cyclobenzaprine hcl tabs 10mg 1000s

cyclobenzaprine hcl tabs 10mg 1000s

Each film-coated tablet contains 10mg of Cyclobenzaprine hydrochloride USP. This medication is manufactured by Rubicon Research Private Limited, located in Ambernath, Dist. Thane, 421506 India, with manufacturing license number KD-682. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. It is recommended to keep the container tightly closed and out of the reach of children. The medication should be stored at 20°C to 25°C (68°F to 77°F) as defined in the USP Controlled Room Temperature. The National Drug Code (NDC) for this product is 52817 332 00, and it is distributed by TruPharma, LLC, located in Tampa, FL 33609.*

cyclobenzaprine hcl tabs 10mg 100s

cyclobenzaprine hcl tabs 10mg 100s

Each film-coated tablet contains 10mg of Cyclobenzaprine Hydrochloride. The tablets are distributed by TruPharma LLC and should be stored in a tightly closed container at temperatures between 20°C to 25°C. The usual dosage and prescribing information should be followed, and the tablets should be kept out of reach of children in a light-resistant container with a child-resistant closure. The tablets are manufactured by Rubicon Research Private Limited in India. The text includes necessary information about the medicine and its distribution, storage, and safety requirements.*

cyclobenzaprine hcl tabs 10mg 500s

cyclobenzaprine hcl tabs 10mg 500s

This is a prescription medication in tablet form containing 10 mg of Cyclobenzaprine hydrochloride USP. The recommended dosage and other detailed prescribing information can be found in the accompanying instructions. The medication should be stored in a tightly closed, light-resistant container at a controlled room temperature and kept out of the reach of children. The manufacturer is Rubicon Research Private Limited located in India, and it is distributed by TruPharma Company based in Tampa, Florida. The label on the medication should read "Rx Only", followed by a specific code.*

cyclobenzaprine hcl tabs 5mg 100s

cyclobenzaprine hcl tabs 5mg 100s

cyclobenzaprine hcl tabs 5mg 500s

cyclobenzaprine hcl tabs 5mg 500s

This is a medication containing Cyclobenzaprine hydrochloride USP in film-coated tablets of 5mg each. It is distributed by TruPharma LLC based in Tampa, FL. The usual dosage and prescribing information should be consulted. The tablets should be dispensed in a tight, light-resistant container with a child-resistant closure, and kept at 20°C to 25°C (68°F to 77°F). The medication should be kept out of reach of children. The manufacturer is listed as H Ambernath, Dist. Thane, but it is not available where this is located. The label indicates that there are 500 tablets.*

cyclobenzaprine hcl tabs 7pt5mg 100s

cyclobenzaprine hcl tabs 7pt5mg 100s

This is a description of a medication called Cyclobenzaprine Hydrochloride USP, which comes in the form of film-coated tablets. Each tablet contains 7.5 mg of the active ingredient. The tablets should be stored at a temperature between 20°C and 25°C and kept in a tight container out of reach of children. The medication is distributed by TruPharma LLC and the manufacturing license number is KD-682.*

cyclobenzaprine hcl tabs structure

cyclobenzaprine hcl tabs structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.